ZEUS System (Zio Watch) vs Rapid RV/LV
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose ZEUS System (Zio Watch) if your primary need is long-term, continuous cardiac rhythm monitoring to detect and characterize atrial fibrillation and other arrhythmias. This wearable, AI-powered solution is ideal for patients requiring extended observation to capture intermittent events and provide comprehensive insights into AFib burden.
View ZEUS System (Zio Watch) →Choose Rapid RV/LV if…
Choose Rapid RV/LV if you require rapid, AI-powered assessment of pulmonary embolism severity directly from CTPA scans. This tool is best suited for acute care settings where quick and objective measurement of right and left ventricle ratios is crucial for guiding treatment decisions and patient triage.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | Rapid RV/LV |
|---|---|---|
| Pricing | Contact vendor | Contact vendor for pricing information. |
| Deployment | Cloud-based system with a wearable device | Unknown |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool A (ZEUS System / Zio Watch) offers a comprehensive usability experience for both patients and providers. Its wearable device is designed for comfort and high patient compliance, supported by a patient app for symptom logging and education. The ZioSuite portal and provider mobile app streamline clinician workflows for report interpretation and patient management.
Clinical Value
ZEUS System (Zio Watch)Both tools are FDA-cleared and provide significant clinical value in their respective areas. However, Tool A (ZEUS System / Zio Watch) offers long-term continuous cardiac monitoring for up to 14 days, with a high diagnostic yield for arrhythmias and 99% physician agreement on its reports. Studies also demonstrate its cost-effectiveness in AFib screening and superior performance compared to other monitoring services.
Pricing & Value
ZEUS System (Zio Watch)While both tools require contacting the vendor for specific pricing, Tool A (ZEUS System / Zio Watch) has published studies demonstrating its cost-effectiveness for AFib screening, with a favorable incremental cost-effectiveness ratio. It also offers patient financial assistance programs, which adds to its overall value proposition.
Enterprise Readiness
Rapid RV/LVBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs. Tool B (Rapid RV/LV) provides more flexible deployment options, including on-premises or hybrid models, and explicitly highlights seamless integration with PACS, RIS, EMR, and other enterprise systems through its comprehensive Rapid Enterpriseu2122 Platform. This adaptability and broad integration capability give it an edge for diverse hospital IT environments.
Innovation
ZEUS System (Zio Watch)Both tools leverage AI for critical healthcare applications. Tool A (ZEUS System / Zio Watch) demonstrates a more disruptive innovation by combining a comfortable, long-term wearable biosensor for continuous cardiac monitoring with advanced AI analysis and patient engagement through a dedicated app. This approach leverages a massive ECG database to redefine the standard of care for early detection and prevention of cardiac conditions.
Support & Docs
Rapid RV/LVTool B (Rapid RV/LV) explicitly states offering 24/7/365 customer support via email and phone across multiple countries and languages, along with extensive resources and training as part of its annual subscription. While Tool A (ZEUS System / Zio Watch) provides customer care and patient/clinician resources, it does not specify the same level of global, round-the-clock availability or detail regarding its documentation and training.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | Rapid RV/LV |
|---|---|---|
| Name | ZEUS System (Zio Watch) | Rapid RV/LV |
| Company | iRhythm Technologies | RapidAI (formerly iSchemaView) |
| Description | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
| Key Features | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection; AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis; Long-term continuous monitoring for up to 14 days; Detects and characterizes Atrial Fibrillation (AFib) burden; Cloud-based data analytics and processing; Clinically actionable reports with high physician agreement (99%); ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management; MyZiou00ae patient app for digital symptom logging, educational content, and reminders | AI-powered analysis of CTPA images; Automated measurement of right and left ventricle diameters; Calculation of RV/LV ratio; Annotated images showing ventricular measurements; Rapid results (within minutes of scan); Reduces inter-rater variability; Integration with Rapid PE solution; Triage and notification capabilities (as part of the broader Rapid platform) |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Rapid RV/LV.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or Rapid RV/LV
Backers
Who funded each tool's parent company.